Vérastem (NASDAQ:VSTM) inventory soared 20% in after-hours buying and selling following information that the FDA has agreed to precedence evaluation of the corporate’s new drug software for accelerated approval of its medication avutometinib and defactinib in remedy of ovarian most cancers, with
#FDA #Accepts #Verastem #NDA #Precedence #Evaluate #Inventory #Jumps #Up to date , #Gossip247
vstm ,
ketchum
elon musk internet value
david bonderman
adobe inventory
nationwide grid
microsoft ai